Search Results - "Barneto Aranda, I C"
-
1
1241P - Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients
Published in Annals of oncology (01-10-2019)“…Immunotherapy has become the main therapy in advanced NSCLC patients, but recently, combination with chemotherapy in locally advanced stages is showing…”
Get full text
Journal Article -
2
1439PDBRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy: SCAT Trial
Published in Annals of oncology (01-10-2019)“…Abstract Background Post-operative platinum-based chemotherapy is the standard of care for resected NSCLC with nodal involvement. Expression of genes involved…”
Get full text
Journal Article -
3
1241PImmune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients
Published in Annals of oncology (01-10-2019)“…Abstract Background Immunotherapy has become the main therapy in advanced NSCLC patients, but recently, combination with chemotherapy in locally advanced…”
Get full text
Journal Article -
4
Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients
Published in Annals of oncology (01-10-2019)Get full text
Journal Article